Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Cell Cycle (Georgetown, Tex.)|April 22, 2006
Regulation of p14ARF through subnuclear compartmentalizationRuth A Gjerset, Keya BandyopadhyayBiochemistry|December 25, 2010
Protein kinase CK2 is a central regulator of topoisomerase I hyperphosphorylation and camptothecin sensitivity in cancer cell linesKeya Bandyopadhyay, Ruth A GjersetPlos One|November 28, 2012
CK2-mediated hyperphosphorylation of topoisomerase I targets serine 506, enhances topoisomerase I-DNA binding, and increases cellular camptothecin sensitivityKeya Bandyopadhyay, Pingchuan Li, Ruth A GjersetPlos One|April 5, 2013
The p14ARF alternate reading frame protein enhances DNA binding of topoisomerase I by interacting with the serine 506-phosphorylated core domainKeya Bandyopadhyay, Pingchuan Li, Ruth A GjersetCancer Research|November 4, 2005
DNA damage disrupts the p14ARF-B23(nucleophosmin) interaction and triggers a transient subnuclear redistribution of p14ARFCasey Lee, Brian A Smith, Keya Bandyopadhyay, et al.Biochemistry|November 17, 2007
Serine phosphorylation-dependent coregulation of topoisomerase I by the p14ARF tumor suppressorKeya Bandyopadhyay, Casey Lee, Ali Haghighi, et al.Cell Cycle (Georgetown, Tex.)|August 5, 2009
Spermidinyl-CoA-based HAT inhibitors block DNA repair and provide cancer-specific chemo- and radiosensitizationKeya Bandyopadhyay, Jean-Louis Banères, Aimée Martin, et al.Journal of Molecular Histology|July 21, 2006
DNA damage, p14ARF, nucleophosmin (NPM/B23), and cancerRuth A GjersetPlos One|August 7, 2015
Topoisomerase-I PS506 as a Dual Function Cancer BiomarkerMing Zhao, Ruth A GjersetCellular & Molecular Immunology|March 15, 2016
NKT cell subsets as key participants in liver physiology and pathologyKeya Bandyopadhyay, Idania Marrero, Vipin KumarPageof 3